Recursion Pharmaceuticals RXRX Q1 2026 Earnings Narrower Loss Surprises Market but Stock Dips on PreRevenue Status BBAI Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter Oscar Health Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction Ducommun DCO Q1 2026 Earnings EPS Falls Short of Estimates Stock Edges Higher SGMT Q1 2026 Earnings EPS Beat as Clinical Development Costs Tighten MediaAlpha MAX Q1 2026 Earnings EPS Misses Estimates Stock Still Rises